Clinical Trials Browser

Phase 1 × Neoplasm Metastasis × Rogaratinib × Clear all

NCT03517956 2022-07-14

ROCOCO

Phase 1 Completed

Neoplasm Metastasis

NCT01976741 2021-05-06

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Phase 1 Completed

168 enrolled 59 charts

GenitourinaryHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms